GH Research (GHRS)
GH Research Statistics
Share Statistics
GH Research has 62.03M shares outstanding. The number of shares has increased by 19.22% in one year.
Shares Outstanding | 62.03M |
Shares Change (YoY) | 19.22% |
Shares Change (QoQ) | 19.22% |
Owned by Institutions (%) | 59% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 873 |
FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 2.88M, so 4.64% of the outstanding shares have been sold short.
Short Interest | 2.88M |
Short % of Shares Out | 4.64% |
Short % of Float | 11.61% |
Short Ratio (days to cover) | 12.27 |
Valuation Ratios
The PE ratio is -9.35 and the forward PE ratio is -6.25. GH Research's PEG ratio is -0.91.
PE Ratio | -9.35 |
Forward PE | -6.25 |
PS Ratio | 0 |
Forward PS | 3.7 |
PB Ratio | 2.04 |
P/FCF Ratio | -8.6 |
PEG Ratio | -0.91 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GH Research.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.23, with a Debt / Equity ratio of 0.
Current Ratio | 17.23 |
Quick Ratio | 17.23 |
Debt / Equity | 0 |
Debt / EBITDA | -0.02 |
Debt / FCF | -0.01 |
Interest Coverage | -70.08 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-779,220 |
Employee Count | 50 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -3.84% in the last 52 weeks. The beta is 0.85, so GH Research's price volatility has been higher than the market average.
Beta | 0.85 |
52-Week Price Change | -3.84% |
50-Day Moving Average | 10.5 |
200-Day Moving Average | 9.66 |
Relative Strength Index (RSI) | 59.49 |
Average Volume (20 Days) | 534,932 |
Income Statement
Revenue | n/a |
Gross Profit | -315K |
Operating Income | -50.25M |
Net Income | -38.96M |
EBITDA | -37.93M |
EBIT | -38.24M |
Earnings Per Share (EPS) | -0.75 |
Balance Sheet
The company has 100.79M in cash and 624K in debt, giving a net cash position of 100.17M.
Cash & Cash Equivalents | 100.79M |
Total Debt | 624K |
Net Cash | 100.17M |
Retained Earnings | -106.45M |
Total Assets | 188.27M |
Working Capital | 145.27M |
Cash Flow
In the last 12 months, operating cash flow was -42.28M and capital expenditures -49K, giving a free cash flow of -42.33M.
Operating Cash Flow | -42.28M |
Capital Expenditures | -49K |
Free Cash Flow | -42.33M |
FCF Per Share | -0.81 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GHRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for GHRS is $32, which is 197.4% higher than the current price. The consensus rating is "Buy".
Price Target | $32 |
Price Target Difference | 197.4% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Scores
Altman Z-Score | 37.51 |
Piotroski F-Score | 2 |